These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37211398)

  • 1. Identification and validation of oxeiptosis-associated lncRNAs and prognosis-related signature genes to predict the immune status in uterine corpus endometrial carcinoma.
    Niu L; Wu Z
    Aging (Albany NY); 2023 May; 15(10):4236-4252. PubMed ID: 37211398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of oxeiptosis-associated lncRNAs and prognosis-related signature to predict the immune status in gastric cancer.
    Wen L; Xu K; Huang M; Pan Q
    Medicine (Baltimore); 2024 Feb; 103(7):e37189. PubMed ID: 38363905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Five m6A-Related lncRNA Genes as Prognostic Markers for Endometrial Cancer Based on TCGA Database.
    Shan L; Lu Y; Xiang CC; Zhu X; Zuo ED; Cheng X
    J Immunol Res; 2022; 2022():2547029. PubMed ID: 35571565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an Immune-Related LncRNA Prognostic Signature in Uterine Corpus Endometrial Carcinoma Patients.
    Sun XX; Wen HQ; Zhan BX; Yang P
    Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic signature construction and immunotherapy response analysis for Uterine Corpus Endometrial Carcinoma based on cuproptosis-related lncRNAs.
    Zhang X; Ye Z; Xiao G; He T
    Comput Biol Med; 2023 Jun; 159():106905. PubMed ID: 37060773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cuproptosis-Associated lncRNA Gene Signature Establishes New Prognostic Profile and Predicts Immunotherapy Response in Endometrial Carcinoma.
    Jiang XY; Hu JJ; Wang R; Zhang WY; Jin QQ; Yang YT; Mei J; Hong L; Yao H; Tao F; Li JJ; Liu Y; Zhang L; Chen SX; Chen G; Song Y; Zhou SG
    Biochem Genet; 2024 Oct; 62(5):3439-3466. PubMed ID: 38108937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma.
    Ouyang D; Li R; Li Y; Zhu X
    J Cell Biochem; 2019 Oct; 120(10):18465-18477. PubMed ID: 31168849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial Carcinoma.
    Xie BF; Xia Y; Lin DH; Lian B; Zhang ML; Liu L; Qin CR
    Comput Intell Neurosci; 2022; 2022():6530884. PubMed ID: 36199963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying immune subtypes of uterine corpus endometrial carcinoma and a four-paired-lncRNA signature with immune-related lncRNAs.
    Li N; Yu K; Lin Z; Zeng D
    Exp Biol Med (Maywood); 2022 Feb; 247(3):221-236. PubMed ID: 34704492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. m6A-related long noncoding RNAs predict prognosis and indicate therapeutic response in endometrial carcinoma.
    Zhou X; Zhang H; Duan Y; Zhu J; Dai H
    J Clin Lab Anal; 2023 Jan; 37(1):e24813. PubMed ID: 36525280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
    Zhou M; Zhang Z; Zhao H; Bao S; Sun J
    BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer.
    Lin Z; Fan W; Sui X; Wang J; Zhao J
    Reprod Sci; 2023 Feb; 30(2):576-589. PubMed ID: 35854199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Clinical Validation of Novel 8-Gene Prognostic Signature Associated With the Proportion of Regulatory T Cells by Weighted Gene Co-Expression Network Analysis in Uterine Corpus Endometrial Carcinoma.
    Liu J; Geng R; Yang S; Shao F; Zhong Z; Yang M; Ni S; Cai L; Bai J
    Front Immunol; 2021; 12():788431. PubMed ID: 34970268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated bioinformatics analysis and experimental validation reveals fatty acid metabolism-related prognostic signature and immune responses for uterine corpus endometrial carcinoma.
    Guo C; He Y; Chen L; Li Y; Wang Y; Bao Y; Zeng N; Jiang F; Zhou H; Zhang L
    Front Oncol; 2022; 12():1030246. PubMed ID: 36439473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of lncRNAs associated with uterine corpus endometrial cancer prognosis based on the competing endogenous RNA network.
    Wang L; Su X; Wang L; Luo J; Xiong Z; Leung GHD; Zhou J; Yang G; Zhai L; Zhang X; Liu Q; Lu G; Wang Y
    Int J Med Sci; 2023; 20(12):1600-1615. PubMed ID: 37859697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a novel DNA damage repair-related long non-coding RNA signature in predicting prognosis, immunity, and drug sensitivity in uterine corpus endometrial carcinoma.
    Wang T; Ji M; Liu W; Sun J
    Comput Struct Biotechnol J; 2023; 21():4944-4959. PubMed ID: 37876625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Hub Genes Correlated With Poor Prognosis for Patients With Uterine Corpus Endometrial Carcinoma by Integrated Bioinformatics Analysis and Experimental Validation.
    Yuan Y; Chen Z; Cai X; He S; Li D; Zhao W
    Front Oncol; 2021; 11():766947. PubMed ID: 34868993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sialylation-associated long non-coding RNA signature predicts the prognosis, tumor microenvironment, and immunotherapy and chemotherapy options in uterine corpus endometrial carcinoma.
    Chen J; Wu T; Yang Y
    Cancer Cell Int; 2024 Sep; 24(1):314. PubMed ID: 39261877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma.
    Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
    Biomed Res Int; 2022; 2022():2056913. PubMed ID: 35937391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative Analysis Reveals a Nine TP53 Pathway-Related lncRNA Prognostic Signature in Endometrial Cancer.
    Wang Y; Qu X; Li L; He D
    Biomed Res Int; 2022; 2022():5432806. PubMed ID: 36262972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.